Sanctions Contagion

The R&D industry, particularly in natural sciences and engineering, exhibits moderate-high structural sanctions contagion and circuitry risk due to the pervasive dual-use nature of its technologies and reliance on international financial systems. Many research inputs and outputs are classified as dual-use and appear on export control lists, placing the sector on a 'Sectoral Watchlist' requiring heightened scrutiny.

• Dual-Use Technologies: Examples include specialized equipment, advanced materials, and high-performance computing components often found on lists like the Wassenaar Arrangement.
• Financial Vulnerability: International R&D projects rely on global banking, making them vulnerable to secondary sanctions if a partner or supplier is targeted, as seen with U.S. Treasury Department's Office of Foreign Assets Control (OFAC) updates. The accelerating designation of critical technologies as dual-use further increases this structural exposure.

The R&D sector experiences moderate-high traceability fragmentation and provenance risk, critically impacting research integrity and reproducibility. While commercial reagents often have lot-level tracking, internal processes within academic and collaborative research environments frequently rely on disparate, non-interoperable systems, including paper logs and fragmented spreadsheets.

• This leads to significant challenges in verifying the origin and custody of critical assets like biological samples and datasets across institutional boundaries, contributing to a reproducibility crisis in science (Nature, 2016).
• Misidentified or contaminated cell lines alone are estimated to affect 15-20% of research publications, undermining research validity and necessitating expensive remediation (International Journal of Cancer, 2010).

Structural integrity and fraud vulnerability in natural sciences and engineering R&D are moderate-high, driven by intense pressure for novel results and career advancement. The 'reproducibility crisis' highlights significant challenges, with studies indicating that between 50% and 89% of research findings are irreproducible, often due to methodological flaws or, in some cases, outright data manipulation.

• Impact: Such vulnerabilities can lead to misallocated funding, delayed scientific progress, and eroded public trust in scientific findings, posing a continuous threat to the industry's foundational principles.